SNWV news

Sanuwave reported Q2 FY2026 revenues of $9.7 million, a 3% decrease from the prior year. The company achieved a record in unit volume for its Ultramist applicators but faced pressure on system sales due to reimbursement changes and a used equipment market.

Sanuwave reported preliminary Q2 2026 revenue of $9.6 million to $9.8 million, surpassing its revised guidance of $8.5 million to $9.5 million. Despite headwinds in capital sales, the company achieved record-high consumable sales, signaling strength in its core business.

Sanuwave Health reduced its Q2 2026 revenue guidance below prior expectations due to CMS reimbursement clawbacks forcing wound care practices to close and flood the market with used Ultramist systems. While consumable applicator volumes remain robust, capital equipment sales face near-term headwinds…